shutterstock_613544495-atmosphere1
Atmosphere1 / Shutterstock.com
21 November 2019Big PharmaSaman Javed

EU General Court sides with Merck in TM opposition

A German individual has lost an appeal before the tribunal of the  EU General Court, after his trademark registration was opposed by Merck.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
14 November 2019   Merck has agreed to license its CRISPR gene-editing technology to German biotech company Evotec.
Big Pharma
9 June 2020   Monster Energy has failed to block a UK trademark filed by German pharmaceutical company Merck KGaA.
Big Pharma
1 July 2020   Japan-based Nitto Pharmaceutical Industries has been blocked from using its ‘Noster’ brand in the EU, in a win for Italian drugmaker Chiesi Farmaceutici.

More on this story

Europe
14 November 2019   Merck has agreed to license its CRISPR gene-editing technology to German biotech company Evotec.
Big Pharma
9 June 2020   Monster Energy has failed to block a UK trademark filed by German pharmaceutical company Merck KGaA.
Big Pharma
1 July 2020   Japan-based Nitto Pharmaceutical Industries has been blocked from using its ‘Noster’ brand in the EU, in a win for Italian drugmaker Chiesi Farmaceutici.

More on this story

Europe
14 November 2019   Merck has agreed to license its CRISPR gene-editing technology to German biotech company Evotec.
Big Pharma
9 June 2020   Monster Energy has failed to block a UK trademark filed by German pharmaceutical company Merck KGaA.
Big Pharma
1 July 2020   Japan-based Nitto Pharmaceutical Industries has been blocked from using its ‘Noster’ brand in the EU, in a win for Italian drugmaker Chiesi Farmaceutici.